The effect of phencyclidine new derivatives on anxiety behaviors in rats

Iranian Journal of Basic Medical Sciences

Volumn 13, Issue 2 SPRING, 2010, Pages 16-23

  Hajkhani, Ramin ^a   Solati, Jalal ^a   Ahmadi, Abbas ^a   Salari, Ali Akbar ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Anxiety; Methyl and methoxy hydroxyl derivatives; Phencyclidine

Indexed keywords

1 [1 (4 METHOXYPHENYL) (CYCLOHEXYL)] 4 PIPERIDINOL; 1 [1 (4 METHYLPHENYL) (CYCLOHEXYL)] 4 PIPERINIDOL; ANXIOLYTIC AGENT; CAS 956 90 1; PHENCYCLIDINE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; MALE; MAZE TEST; NEUROMODULATION; NONHUMAN; RAT; TASK PERFORMANCE; WISTAR RAT;

RATTUS; RATTUS NORVEGICUS;

EID: 77952784722     PISSN: 20083866     EISSN: 20083874     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Greifenstein FE,Yoshitake J, De Vaulet M, Gajewski JE. A study of 1-arylcyclohexylamine for anesthesia. Anesth Analg 1958; 37:283-284.
2. Ahmadi A, Shafiezadeh M, Fathollahi Y. Synthesis with improved yield and study on analgesic effect of 2- hydroxyphencyclidine. Arzneimittelforschung 2005; 55:172-176. (Pubitemid 40460020)
3. Al-deeb OAA. Synthesis and analgesic activity of new phencyclidine derivatives. Arzneimittelforschung 1994; 44:1141-1144.
4. Mori A, Noda Y, Mamiya T, Miamoto Y, Nakajima A, Furukawa H, et al. Phencyclidine-induced discriminative stimulus is mediated via phencyclidine binding sites on the N-methyl-D-asparate receptor-ion channel complex, not via sigma receptors. Behav Brain Res 2001; 119:33-40. (Pubitemid 32063352)
5. Geller EB, Adler LH, Wojno C, Adler MW.The anticonvulsant effect of phencyclidine in rats. Psychopharmacology 1981; 74:97-98. (Pubitemid 11126468)
6. Chen G, Weston JK. The analgesic and anesthetic effects of 1-(1-phenylcyclohexyl) piperidine.HCl on the monkey. Anesth Analg 1960; 39:132-137.
7. Olney JW, Labruyere J, Wang G, Wozniak DF, Price MT, Sesma MA. NMDA antagonist neurotoxicity: mechanism and prevention. Science 1991; 254:1515-1518. (Pubitemid 21917493)
8. Kapur S, Seeman P. NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D (2) and serotonin 5-HT(2) receptors-implications for models of schizophrenia. Mol Psychiatry 2002; 7:837-844.
9. Honey CR, Miljkovic Z, McDonald JF. Ketamine and phencyclidine cause a voltage-dependent block of responses to L-aspartic acid. Neurosci Lett 1985; 61:135-139. (Pubitemid 16201138)
10. Lal H, Emmett-Oglesby MW. Behavioral analogues of anxiety. Animal models. Neuropharmacology 1983; 22:1423-1441.
11. Griez EJL.Anxiety disorders:an introduction to clinical management and research. John Wiley and Sons, 2001.
12. Ninan PT. The functional anatomy, neurochemistry, and pharmacology of anxiety. J Clin Psychiatry 1999; 22:12-17.
13. Stephens DN, Meldrum BS, Weidmann R, Schneider C, Grutzner M. Does the excitatory amino acid receptor antagonist 2-aph exhibit anxiolytic activity? Psychopharmacology 1986; 90:166-169.
14. Souza-Pinto LF, Castilho VM, Brandao ML, Nobre MJ. The blockade of ampa-kainate and nmda receptors in the dorsal periaqueductal gray reduces the effects of diazepam withdrawal in rats.Pharmacol Biochem Behav 2007; 87:250-257.
15. Guimarães FS, Carobrez AP, Aguiar JC, Graeff FG. Anxiolytic effect in the elevated plus-maze of the NMDA receptor antagonist ap7 microinjected into the dorsal periaqueductal grey. Psychopharmacology (Berl) 1991; 103:91-94.
16. Plaznik A, Palejko W, Nazar M, Jessa M. Effects of antagonists at the NMDA receptor complex in two models of anxiety. Eur Neuropsychopharmacol 1994; 4:503-512.
17. Woolverton WL, Balster RL. Tolerance to the behavioral effects of phencyclidine: the importance of behavioral and pharmacological variables. Psychopharmacology 1979; 64:19-24. (Pubitemid 9227039)
18. Vaupel DB, McCoun D, Cone EJ. Phencyclidine analogs and precursors: rotarod and lethal dose studies in the mouse. J Pharmacol. 1984; 230: 20-27.
19. Maddox VH, Godefroi EF, Parcell RF. The synthesis of phencyclidine and other 1-arylcyclohexylamines. J Med Chem 1965; 8:230-235.
20. Ahmadi A, Khalili M, Abbassi S, Javadi M, Mahmoudi A, Hajikhani R. Synthesis and study on analgesic effects of 1-[1-(4-methylphenyl) (cyclohexyl)] 4-piperidinol and 1-[1-(4-methoxyphenyl) (cyclohexyl)] 4- piperidinol as two new phencyclidine derivatives. Accepted to published in Arzneimittelforschung 2009.
21. Zarrindast MR, Solati J, Oryan S, Parivar K. Effect of intra-amygdala injection of nicotine and gaba receptor agents on anxiety-like behavior in rats. Pharmacology 2008; 82:276-284.
22. Wieronska JM, Szewczyk B, Palucha A, Branski P, Zieba B, Smialowska M. Anxiolytic action of group ii and iii metabotropic glutamate receptors agonists involves neuropeptide y in the amygdala. Pharmacol Rep 2005; 57:734-743.
23. Linden AM, Baez M, Bergeron M, Schoepp DD. Effects of mglu2 or mglu3 receptor deletions on mglu2/3 receptor agonist (ly354740)-induced brain c-fos expression: Specific roles for mglu2 in the amygdala and subcortical nuclei, and mglu3 in the hippocampus. Neuropharmacology 2006; 51:213-228.
24. Linden AM, Greene SJ, Bergeron M, Schoepp DD. Anxiolytic activity of the mglu2/3 receptor agonist ly354740 on the elevated plus maze is associated with the suppression of stress-induced c-fos in the hippocampus and increases in c-fos induction in several other stress-sensitive brain regions. Neuropsychopharmacology 2004; 29:502-513.
25. Linden AM, Shannon H, Baez M, Yu JL, Koester A, Schoepp DD. Anxiolytic-like activity of the mglu2/3 receptor agonist ly354740 in the elevated plus maze test is disrupted in metabotropic glutamate receptor 2 and 3 knock-out mice. Psychopharmacology 2005; 179:284-291.
26. Anthony EW, Nevins ME. Anxiolytic-like effects of n-methyl-d-aspartate- associated glycine receptor ligands in the rat potentiated startle test. Eur J Pharmacol 1993; 250:317-324.
27. Adamec R. Evidence that NMDA-dependent limbic neural plasticity in the right hemisphere mediates pharmacological stressor (FG-7142)-induced lasting increases in anxiety-like behavior: Study 1-Role of NMDA receptors in efferent transmission from the cat amygdala. J Psychopharmacol 1998; 12:122.
28. Adamec R. Transmitter systems involved in neural plasticity undelying increased anxiety and defense- Implications for understanding anxiety following traumatic stress. Neurosci Biobehav Rev 1997; 21:755-765.
29. Hucho F. The nicotinic acetylcholine receptor and its ion channel. Eur J Biochem 1986; 158:211-226.
30. Ochoa EL,Li L, McNamee MG. Desensitization of central cholinergic mechanisms and neuroadaptation to nicotine. Mol Neurobiol 1990; 4:251-287.
31. Olney J, Newcomer J. NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res 1999; 33:523-533.
32. Martin P, Carlsson M. Systemic PCP treatment elevates brain extracellular 5-H-T: a microdialysis study in awaker rats. Neuroreport 1998; 9:2985.
33. Graeff F, Guimarães F. Role of 5-HT in stress, anxiety, and depression. Pharmacol Biochem Behav 1996; 54: 129-142.
34. Shebley M, Jushchyshyn MI, Hollenberg F. Selective pathways for the metabolism of phencyclidine by cytochrome P450 2B enzymes: identification of electrophilic methabolites, glutathione and N-acetyl cysteine adducts. Drug Metab Dispos 2006; 34:375-383.
35. Nabeshima T, Yamaguchi K, Hiramatsu M, Amano M, Furukawa H, Kameyama T. Serotonergic involvement in phencyclidine-induced behaviors. Pharmacol Biochem Behav 1984; 21:401-408.
36. Moon BH, Hong CG, Kim SY, Kim HJ, Shin SK, Kang S, et al. A single administration of 2,3,7,8- tetrachlorodibenzo-p-dioxin that produces reduced food and water intake induces long-lasting expression of corticotropin-releasing factor, arginine vasopressin,and proopiomelanocortin in rat brain. Toxicol Applied Pharmacol 2008; 233:314-322.
37. Ingold K. Structure and mechanism in organic chemistry. N.Y. Ithaca: Cornell University Press; 1953.